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Abstract
Background—Elevated concentrations of homocysteine in blood may be an independent risk factor
for the development of atherosclerosis. Elevated homocysteine concentrations can be caused by
decreased methylation of homocysteine to form methionine, as occurs in folate deficiency. A parallel
pathway exists for methylation of homocysteine, in which choline, by way of betaine, is the methyl
donor.
Objective—Our goal was to determine whether choline deficiency results in a decreased capacity
to methylate homocysteine.
Design—C57BL/6J mice were fed diets containing 0, 10, or 35 mmol choline/kg diet for 3 wk. We
then administered an oral methionine load to the animals and measured plasma homocysteine
concentrations. Also, in a pilot study, we examined 8 men who were fed a diet providing 550 mg
choline/d per 70 kg body weight for 10 d, followed by a diet providing almost no choline, until the
subjects were clinically judged to be choline deficient or for ≤42 d. A methionine load was
administered at the end of each dietary phase.
Results—Two hours after the methionine load, choline-deficient mice had plasma homocysteine
concentrations twice those of cholinefed mice. Four hours after the methionine load, clinically
choline-depleted men had plasma homocysteine concentrations that were 35% greater than those in
men not choline depleted.
Conclusion—These results suggest that choline, like folate, plays an important role in the
metabolism of homocysteine in humans and that response to a methionine load may be useful when
assessing choline nutriture.
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INTRODUCTION
Epidemiologic studies have shown that an elevated total plasma homocysteine concentration
is correlated with an increased risk of atherosclerotic vascular disease (1,2). Homocysteine is
2Presented in part in poster form at Experimental Biology 2004, Washington, DC (FASEB J 2004;18:A5410).
3Supported by a grant from the National Institutes of Health (DK55865) and by grants from the NIH to the University of North Carolina
Clinical Nutrition Research Unit (DK56350), General Clinical Research Center (RR00046), and the Center for Environmental Health
and Susceptibility (ES10126).
Address reprint requests to SH Zeisel, Department of Nutrition, School of Public Health and School of Medicine, University of North
Carolina at Chapel Hill, CB# 7461, Chapel Hill, NC 27599. E-mail: steven_zeisel@unc.edu.
NIH Public Access
Author Manuscript
Am J Clin Nutr. Author manuscript; available in PMC 2008 June 10.
Published in final edited form as:













metabolized by conversion to sulfur amino acids, and mutations in cystathionine β-synthase,
the catabolic enzyme that requires vitamin B-6, result in hyperhomocysteinemia (3). In
addition, homocysteine can be methylated to form methionine (3) by 2 parallel pathways, both
of which lower homocysteine concentrations. In the first pathway, vitamin B-12 and folic acid
are involved in a reaction catalyzed by methionine synthase (4). Deficiency of these nutrients
(5,6), or single nucleotide polymorphisms in the genes for the enzymes involved in this pathway
(4,6,7), can result in elevated plasma homocysteine concentrations. The alternative pathway
for the methylation of homocysteine to form methionine is catalyzed by betaine homocysteine
methyltransferase (8), an enzyme whose activity was reported to increase in rats during
methionine excess (9). Betaine, derived from dietary choline, is the methyl group donor in this
reaction, and supplemental oral betaine can lower plasma homocysteine concentrations (10,
11). Choline is an essential nutrient (12), and humans can become depleted of it (13,14). In
this study we examined whether dietary choline deficiency was associated with a decreased




DL-Homocysteine, cysteamine, reduced glutathionine, and SBD-F (7-fluorobenzo-2-oxa-1,3-
diazole-4-sulfonic acid, ammonium salt) were purchased from Sigma Chemical Co (St Louis).
L-Cysteine came from Aldrich (Milwaukee), and TCEP-HCl [tris (2-carboxyethyl) phosphine
hydrochloride] was obtained from Pierce (Rockford, IL). The other reagents were obtained
from Fisher Scientific (Fair Lawn, NJ).
Animals and diets
All animal procedures were approved by the University of North Carolina Institutional Animal
Care and Use Committee. Male C57BL/6J mice (Jackson Labs, Bar Harbor, ME), 25 g body
weight, were housed individually in tubs in a climate-controlled room (24 °C) exposed to light
from 0600 to 1800 daily. They were given free access to water and pelleted diets (Dyets,
Bethlehem, PA) for 3 wk. Three AIN-93G diets were used, containing 35 mmol choline/kg
diet (choline supplemented, CS), 10 mmol choline/kg diet (control), or 0 mmol choline/kg diet
(choline deficient, CD). These AIN-93G diets contained 5.2 g methionine/kg, 2 mg folate/kg,
7 mg vitamin B-6/kg, and 0.025 mg vitamin B-12/kg, which meets the rodent requirement for
these nutrients (15).
For the study in mice, on the morning of the last day of the diet period, half of the mice in each
group (n = 7/group in CD; n = 5/group in control and CS mice) were anesthetized (200 mg
ketamine/kg and 16 mg xylazine/kg), and blood was collected by cardiac puncture. Heparin
was added to the sample, and the plasma was separated by centrifugation (1000 × g for 10 min
at 4 °C). The livers from the exsanguinated mice were then collected by freeze-clamping them
with tongs precooled in liquid nitrogen, and the animals died. All the samples were then stored
at −80 °C until further analysis. L-Methionine was administered to the remaining animals by
oral gavage at a dose of 100 mg/kg body weight. Two hours later, these mice were anesthetized
and exsanguinated by cardiac puncture, plasma and livers were collected and stored as stated
above, and the mice died. Homocysteine was measured 2 h after the methionine load in the
mice because previous work in rats indicated a maximal response by that time (16).
Human study
Eight healthy male volunteers aged 20–46 y (5 whites and 3 African Americans) with body
mass indexes (in kg/m2) ranging from 20 to 33, were recruited for a protocol approved by the
Institutional Review Board at the University of North Carolina at Chapel Hill. Subjects were
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admitted to the General Clinical Research Center and administered various research diets. A
description of these diets has been published elsewhere (17,18). Specifically, subjects were fed
for 10 d a baseline diet of normal foods containing 550 mg choline/d per 70 kg body weight,
which is approximately the current presumed adequate intake (12); the choline content of the
diet was assayed by our laboratory (19). On the morning of day 10, a blood sample was collected
from the subjects. Then the subjects were given L-methionine (100 mg/kg body weight) orally,
and 4 h later blood was collected for the measurement of homocysteine concentrations. Subjects
were then switched to a choline depletion diet containing <50 mg choline/d per 70 kg body
weight for ≤42 d or until they were judged to be choline deficient [developed hepatic steatosis,
as measured by magnetic resonance imaging (MRI)]. On the morning after subjects were
determined to be choline deficient, or after 42 d on the experimental diet, a blood sample was
collected from subjects. Then they were given L-methionine (100 mg/kg body weight) orally,
and 4 h later blood was collected for the measurement of homocysteine concentrations. After
these measurements, subjects not deemed to be clinically choline deficient by MRI were fed
the 550-mg choline diet for 3 d and then discharged. Subjects deemed to be clinically choline
deficient were fed diets containing graded amounts of choline (sequentially in 10-d periods;
containing 138, 275, 413, or 550 mg choline/d per 70 kg body weight) until hepatic steatosis
resolved by MRI and they were judged not to be clinically choline deficient. These subjects,
on the last day of the repletion diet, were given L-methionine orally (100 mg/kg body weight),
and 4 h later blood was collected and homocysteine concentrations were measured.
The diets were composed of 0.8 g high-biologic-value protein/kg body weight, with 30% kcal
coming from fat and the remaining kcal from carbohydrate. The diets met or exceeded the
estimated average requirement for methionine plus cysteine and the daily reference intake for
vitamin B-6, vitamin B-12, and folate (400 dietary folate equivalents/d).
Analytic methods
We used an HPLC method to measure total plasma homocysteine concentrations (20). We used
a Dynamax HPLC system (model SD-200; Rainin Instruments, Woburn, MA) with a
Microsorb-MV C18 column (5 μm, 100 A, 25 cm; Varian Inc, Walnut Creek, CA) and
fluorescence spectrophotometric detector (Varian Prostar model 360) at EX 385 nm, EM 515
nm wavelength. Cysteamine was the internal standard used to correct for recovery. Blood
samples from the human study also were analyzed by an independent laboratory at the
University of Colorado Health Sciences Center (Denver) with use of gas chromatography–
mass spectrometry methods to confirm plasma homocysteine concentrations (21).
Choline and metabolites, folate, and triacylglycerols
Choline and its metabolites were extracted from liver tissue and human plasma by the method
of Bligh and Dyer (22). Aqueous and organic compounds were separated, analyzed, and
quantified directly by HPLC-mass spectrometry (liquid chromatography and electrospray
ionization–isotope dilution mass spectrometry) after the addition of internal standards labeled
with stable isotopes that were used to correct for recovery (23). Plasma folate concentrations
were measured with the use of a microbiological assay (24). Lipids were extracted from mouse
liver tissue by the method of Bligh and Dyer (22), dried, and resuspended in 100 μL
isopropanol, 1% Triton X-100 for ≥1 h. Triacylglycerols were quantified against a standard
with use of the Stanbio enzymatic colorimetric triacylglycerol assay (Boerne, TX).
Statistical analysis
In the mouse study, significant differences between fasting and methionine load homocysteine
concentrations in plasma were determined by Student’s t test. Data were analyzed by two-
factor analysis of variance (ANOVA) with interaction to determine whether differences in
methionine-load status varied by diet. Differences among the 6 groups defined by combinations
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of methionine-load status and diet were determined by using 1-factor ANOVA and the Tukey-
Kramer critical difference test. In the human study, for each metabolite, a two-sample t test
based on the differences between the metabolite concentrations for the 2 diets was used to
compare the clinically depleted and the not depleted groups. Significant differences between
the diets were determined by paired t test, and 95% CIs were calculated for changes in
homocysteine concentration by depletion status. Statistics were performed with the use of JMP
software, version 3.2 (SAS Institute Inc, Cary, NC).
RESULTS
The mean (± SE) homocysteine concentration in mouse plasma at the beginning of our study
was 4.4 ± 0.6 μmol/L (n = 4), which was similar to published values (25). After 3 wk of the
various diets, no significant difference was observed in plasma homocysteine concentrations
between the CS (4.4 ± 0.4 μmol/L; n = 5), control (4.8 ± 0.2 μmol/L; n = 5), and CD (4.2 ± 0.2
μmol/L; n = 7) groups (Figure 1, hatched bars). There was, however, a significant interaction
between methionine-load status and diet (P < 0.001). In cholinefed mice (control + CS groups),
an oral dose of methionine increased plasma homocysteine concentrations at least 2-fold 2 h
after the dose compared with mice not given a methionine load (4.6 ± 0.7 compared with 11.4
± 3.9 μmol/L; P < 0.01, Student’s t test; Figure 1). After a methionine load, CD mice had
plasma homocysteine concentrations 5 times (25.0 ± 3.7 μmol/L; P < 0.01, Student’s t test;
Figure 1, solid bars) those of CD mice not given a methionine load and twice those in the CS
(12.6 ± 2.3 μmol/L) and control (10.2 ± 1.1 μmol/L; P < 0.01, ANOVA; Figure 1 solid bars)
mice given a methionine load.
After 3 wk on the experimental diets, livers from the CD mice had 68% less phosphocholine
(Table 1; P < 0.001, Student’s t test), 38% less choline (P < 0.05), and 14% less
phosphatidylcholine (P < 0.01) than livers from the mice fed 10 mmol choline/kg diet.
Concentrations of other metabolites of choline such as betaine, glycerophosphocholine, and
sphingomyelin did not change with choline deficiency (Table 1), nor did hepatic
triacylglycerols (Table 1; P = 0.142, Student’s t test). Plasma folate concentrations were within
the normal range and also did not differ between the groups (Table 1; P = 0.867, Student’s t
test). We previously reported that choline and triacylglycerol data from mice supplemented
with 35 mmol choline/kg diet (not shown) were not different from the mice fed 10 mmol
choline/kg diet (26).
In the human study, all 8 subjects on the 550-mg choline baseline diet responded to the
methionine load by increasing their mean plasma homocysteine concentration from 6.4 ± 0.6
to 18.5 ± 2.4 μmol/L (P = 0.00053, paired t test). Hepatic steatosis develops in choline-deficient
humans because choline moiety is needed to secrete VLDL from liver (13,27); we selected this
as a clinically important marker for functional changes associated with choline deficiency.
During the choline-depletion phase, hepatic steatosis was measured by MRI at 21 and 42 d.
Four of the subjects on the 50 mg choline depletion diet were judged to be clinically choline
depleted (2 at day 21, 2 at day 42) because they developed hepatic steatosis, and 4 subjects
were not judged to be clinically depleted by the end of the study (day 42). At the end of the
depletion diet phase, fasting plasma homocysteine concentrations (Figure 2) increased by 1.3
μmol/L (95% CI: 0.8, 1.8; P = 0.004) in the subjects judged to be clinically choline depleted
and increased by 0.8 μmol/L (95% CI: −1.3, 2.9; P = 0.309) in the subjects not deemed to be
clinically depleted. After a methionine load (at the end of the depletion diet phase), in the
clinically choline-depleted group, plasma homocysteine concentrations rose 5.2 μmol/L (95%
CI: 1.2, 9.1; P = 0.025; Figure 2) above that which was previously observed after a methionine
load with the 550-mg choline diet. After a methionine load (at the end of the depletion diet
phase), in the group that was not judged to be clinically choline depleted, plasma homocysteine
concentrations did not increase above the amounts previously observed when subjects were on
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the 550-mg diet and received a methionine load (−0.3 μmol/L; 95% CI: −3.5, 2.87; P = 0.761).
By two-sample t test, there was a significant interaction between methionine load and clinical
status (P = 0.014). After choline-deficient subjects consumed the repletion diets and were found
to no longer have hepatic steatosis, plasma homocysteine concentrations returned to baseline
values (6.5 ± 0.4 μmol/L), and response to a methionine load was not different from that seen
on the 550-mg diet (increasing to homocysteine of 15.2 ± 1.5 μmol/L after the load).
In all 8 human subjects, plasma choline and betaine concentrations fell 30% and 47%,
respectively, at the end of the depletion phase (Table 2; P < 0.005, paired t test). Subjects who
were judged to be clinically depleted had decreases in plasma choline and betaine
concentrations that were not different from those observed in subjects not deemed to be
clinically depleted (Table 2). Phosphatidylcholine concentrations in plasma did not change
significantly with the diet (Table 2; P = 0.304, paired t test), nor did plasma folate
concentrations (Table 2; P = 0.233, paired t test).
DISCUSSION
The present study shows that, among its other functions, choline may be important for lowering
plasma homocysteine concentrations even when dietary consumption of folate and other B
vitamins is adequate. In our mouse study, for a better comparison with the human study, we
used AIN 93G diets for the animals [instead of the more restrictive diets we used in the past
that limited folate and methionine as well as choline (28)] and this depleted liver choline
compounds but did not cause hepatic steatosis in mice. With this mild choline depletion, the
plasma homocysteine concentrations in all the groups at 3 wk on experimental diets were not
significantly different from each other. This latter observation was noted by others (29). This
modest choline depletion could not be detected by only measuring plasma homocysteine
concentrations in the absence of a methionine load. This lack of detection was probably
because, when homocysteine flux is low, the folate-dependent methylation pathways are
sufficient for homocysteine removal. We used a methionine load test to increase homocysteine
synthesis and consequently to test the capacity of the homocysteine catabolic system under
stress. Mice given a methionine load had almost 3-fold higher plasma homocysteine
concentrations than mice not given a methionine load. The increase in homocysteine
concentration after load was significantly higher in the CD mice than the other groups. Thus,
when homocysteine flux was high, folate-dependent methylation was limiting and choline-
betaine dependent methylation became critical.
In the human study, the diets similarly contained the recommended daily amounts of folate
and B vitamins. Half of the subjects fed a choline-deficient diet eventually became clinically
symptomatic of choline depletion (developing hepatic steatosis). The fasting plasma
homocysteine concentrations in these depleted humans were increased more than in individuals
who were judged not to be clinically depleted. This difference was even greater after a
methionine load. Thus, in both mice and humans we showed that, when homocysteine flux
was high, folate-dependent methylation was limiting and choline-betaine dependent
methylation became critical.
We do not understand why half of the human subjects did not develop hepatic steatosis while
on a choline-deficient diet. We hypothesized that their endogenous synthesis of choline by way
of phosphatidylethanolamine N-methyltransferase (30) may have been greater than that in the
subjects who did develop steatosis. It is important to note that measurement of plasma choline
or betaine concentrations was not sufficient to predict which subjects would develop organ
dysfunction, because all depleted subjects had low plasma choline and betaine concentrations.
We were able to identify subjects who were sufficiently depleted of choline so as to develop
hepatic steatosis by using a methionine-loading test. Also, this test would yield yet another
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important indicator, betaine after a methionine load, which was found in a recent report (9) to
have a strong inverse association with the increase in homocysteine after methionine load. We
suggest that clinicians use this test as a complement to plasma choline concentrations to identify
patients who are clinically choline depleted. For example, the methionine-load test would be
useful for evaluating patients fed total parenteral nutrition who become choline depleted and
can develop steatosis (14,31–33). If it is known that the patient has normal plasma or
erythrocyte folate concentrations, a plasma choline determination and a methionine-loading
test could predict which patients are likely to be at risk of organ dysfunction associated with
choline deficiency. We suggest that it would be this group that would be most responsive to
treatment with a supplemental source of choline (14).
Our study showed that when homocysteine flux is high, the folate-dependent pathway for
methylation of homocysteine is limiting and the choline-betaine–dependent pathway becomes
important; this finding is consistent with the conclusions of other investigators (9). On the basis
of this information, we suggest that the methionine-load test is useful for detecting choline
deficiency in humans.
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Mean (±SE) plasma homocysteine concentrations in mice fed AIN-93G diets containing 0
(choline deficient, CD), 10 (control, C), or 35 (choline supplemented, CS) mmol choline/kg
diet for 3 wk followed by a methionine load (100 mg/kg body weight). Blood was collected,
plasma was separated, and homocysteine concentrations were measured by HPLC before
(cross-hatched bars) and 2 h after (solid bars) the methionine load; n = 5–7/group. There was
a significant (P < 0.001) methionine-load status × diet interaction. *Significantly different from
fasting (no methionine load), P < 0.01 (Student’s t test). #Significantly different from all other
groups, P < 0.01 (ANOVA and Tukey-Kramer test).
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Change (Δ) in plasma homocysteine (Hcy) concentrations in 8 healthy men fed a 550-mg
choline baseline diet for 10 d, followed by a 50-mg choline depletion diet for ≤42 d, before
and after a methionine load (100 mg/kg body weight). Subjects with hepatic steatosis (n = 4)
were judged to be clinically choline depleted (D) and were offered a repletion diet until hepatic
steatosis resolved. Subjects without hepatic steatosis at the end of the depletion phase (n = 4)
were deemed not to be depleted (ND). Plasma Hcy was measured at the end of each phase
before and 4 h after the methionine load. Hcy concentrations rose from 6.4 ± 0.6 μmol/L before
the methionine load to 18.5 ± 2.4 μmol/L after the methionine load in men fed the 550-mg diet
(n = 8; P < 0.001, paired t test). A significant (P < 0.05) interaction was observed between
methionine load and clinical status. The change in Hcy concentration was calculated as follows:
depletion diet – 550-mg diet. Brackets represent 95%CIs.
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TABLE 1
Liver concentrations of choline and its metabolites in control and choline-deficient mice1
Control mice Choline-deficient mice
Betaine (nmol/mg protein) 1.3 ± 0.3 1.1 ± 0.3
Choline (nmol/mg protein) 2.5 ± 0.4 1.6 ± 0.22
Glycerophosphocholine (nmol/mg protein) 2.1 ± 0.3 2.0 ± 0.2
Phosphocholine (nmol/mg protein) 1.5 ± 0.1 0.5 ± 0.22
Phosphatidylcholine (nmol/mg protein) 123.9 ± 2.5 107.0 ± 5.22
Sphingomyelin (nmol/mg protein) 10.8 ± 0.6 10.1 ± 0.8
Triacylglycerols (nmol/mg protein)3 277.2 ± 28.2 330.0 ± 13.5
Folate (nmol/mL plasma)4 20.8 ± 2.2 20.1 ± 4.0
1
All values are x¯ ± SE; n = 6/group unless noted otherwise. Mice were fed a control (10 mmol choline/kg diet) or choline-deficient (0 mmol choline/kg
diet) diet for 3 wk. Livers were collected, extracted, and analyzed by liquid chromatography and electrospray ionization–isotope dilution mass spectrometry
for choline and its metabolites and by a colorimetric assay for triacylglycerols. Plasma folate was measured with a microbiological assay.
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TABLE 2
Plasma concentrations of choline and its metabolites in humans fed a choline-deficient diet or a diet providing 550 mg choline/
d1
550-mg Choline diet Choline-deficient diet
nmol/mL plasma
Choline
 Clinically depleted 10 ± 1 7 ± 12
 Not depleted 10 ± 1 7 ± 12
 Total group 10 ± 1 8 ± 12
Betaine
 Clinically depleted 74 ± 10 36 ± 43
 Not depleted 55 ± 2 34 ± 23
 Total group 66 ± 7 35 ± 22
Phosphatidylcholine
 Clinically depleted 1876 ± 234 1564 ± 136
 Not depleted 1810 ± 97 1834 ± 40
 Total group 1818 ± 128 1699 ± 83
Folate
 Clinically depleted 22 ± 3 29 ± 4
 Not depleted 31 ± 3 30 ± 3
 Total group 26 ± 3 30 ± 2
1
All values are x̄ ± SE; n = 8. The subjects were fed a 550-mg choline baseline diet for 10 d, followed by a 50-mg choline-depletion diet for ≤42 d. The
subjects with hepatic steatosis were judged to be clinically choline depleted (n = 4) and were offered a repletion diet until hepatic steatosis resolved. The
subjects without hepatic steatosis at the end of the depletion phase (n = 4) were deemed not to be depleted. Blood was collected at the end of each dietary
phase and plasma was separated, extracted, and analyzed by liquid chromatography and electrospray ionization–isotopic dilution mass spectrometry for
choline and its metabolites and by a microbiological assay for folate. There was no interaction between diet and clinical status. Changes in betaine and
choline during consumption of the depletion diet in the subjects who became depleted were not significantly different from those in the subjects who did
not become depleted.
2,3
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